Vasculitis Clinical Research Consortium09/01/2014 - 08/31/2024 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NIAMS2U54AR057319-12
Identification of Shared Molecular Targets07/01/2017 - 06/30/2024 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NCATS9U01TR001263-11
Mepolizumab Long-term Access Programme for Subjects who Participated in Study MEA11592112/24/2015 - 06/30/2020 (PI)
GlaxoSmithKline LLC
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculiti02/28/2017 - 02/27/2020 (PI)
ChemoCentryx, Inc.
Vasculitis Clinical Research Consortium-ARAMIS Pilot01/01/2017 - 08/31/2019 (Co-Investigator)
The Trustees of the University of Pennsylvania NIH NIAMS5U54AR057319-16
Prospective, Observational Safety Study of Patients with Wegener's Granulomatosis (Granulomatosis with Polyangitis) or Microscopic Polyangitis Treated with Rituximab03/01/2012 - 02/28/2019 (PI)
Hoffmann-La Roche Inc (Foreign)
A Double-blind, Randomised, Placebo-controlled Study to Investigate the Efficacy and Safety of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Subjects Receiving Stand09/24/2014 - 12/31/2018 (PI)
GlaxoSmithKline LLC
Vasculitis Clinical Research Foundation09/01/2017 - 08/31/2018 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NIAMS5U54AR057319-15
Adaptation and Validation of PROMIS for use in Vasculitis09/15/2012 - 08/31/2018 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NIAMS5R01AR064153-04
Novel Methods for the Conduct of Clinical Trials06/01/2016 - 05/31/2018 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NHLBI4R01HL115041-04
Showing 10 of 23 results.
Show All Results
Prospective, Observational Safety Study of Patients with Wegener's Granulomatosis (Granulomatosis with Polyangitis) or Microscopic Polyangitis Treated with Rituximab03/01/2012 - 02/28/2018 (PI)
Hoffmann-La Roche Inc (Foreign)
Vasculitis Clinical Research Consortium09/01/2016 - 08/31/2017 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NIAMS5U54AR057319-14
Vasculitis Clinical Research Foundation09/01/2015 - 08/31/2017 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NIAMS5U54AR057319-13
Plasma Exchange and Glucocorticoids for Treatment of ANCA-Associated Vasculitis07/01/2015 - 06/30/2016 (Subcontract PI)
The Trustees of the University of Pennsylvania HHS FDA4R01FD003516-05
RITAZAREM: An International, Open Label, Randomized, Controlled Trial Comparing Rituximab with Azathioprine as Maintenance Therapy in Relapsing ANCA-Associated Vasculitis06/01/2013 - 06/30/2016 (Subcontract PI)
The Trustees of the University of Pennsylvania Genentech, Inc
Novel Methods for the Conduct of Clinical Trials09/01/2012 - 05/31/2016 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NHLBI5R01HL115041-03
Plasma Exchange and Glucocorticoids for Treatment of ANCA-Associated Vasculitis07/01/2014 - 06/30/2015 (Subcontract PI)
The Trustees of the University of Pennsylvania HHS FDA5R01FD003516-04
Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu's Arteritis to Examine the Safety, Efficacy, and Immunologic Effects of Abatrecept in Large Vessel Vasculitis08/15/2007 - 06/14/2015 (Subcontract PI)
Cleveland Clinic Lerner College of Medicine/CWRU NIH NHLBI
A Phase 3, Multi-Center, Multinational, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination with Azathioprine for the Maintenance of Remission in W09/17/2013 - 12/31/2014 (PI)
Human Genome Sciences Inc
Vasculitis Clinical Research Consortium08/01/2012 - 08/31/2014 (Subcontract PI)
The Trustees of the University of Pennsylvania NIH NIAMS5U54AR057319-11
PEXIVAS Clinical Trial01/01/2012 - 06/30/2014 (Subcontract PI)
The Trustees of the University of Pennsylvania HHS FDA5R01FD003516-04
Clinical course and clinical outcomes among subjects with AAV and renal disease in the Rave Cohort06/01/2013 - 05/31/2014 (Subcontract PI)
Mayo Clinic Genentech, Inc
The collaborative network for clinical research in immune tolerance07/01/2012 - 09/30/2013 (Subcontract PI)
The Regents of the University of California NIH NIAID